malities in lymphocyte response to mitogen,' proportional distribution of lymphocyte subtypes,2`4 leucocyte migration inhibition,5 antibody-dependent cell-mediated cytotoxicity,6 and serum inhibition of mitogen response7 have been described. In patients with systemic lupus erythematosus (SLE),8 9 Hodgkin's disease,'0 sacroidosis,1' and tuberculosis'2 poor responses of peripheral blood mononuclear cells to phytohaemagglutinin (PHA) appear to be due at least in part to adherent mononuclear cells or to their soluble products. This report extends these observations to patients with PSS and demonstrates a more severe abnormality than previously seen with SLE.
Materials and methods
Patients. Patients with PSS and normal volunteers were studied. The patients were not selected on the basis of activity of disease or concurrent therapy. Most were untreated; 2 of 13 in the first set of experiments took corticosteroids (5) (6) (7) (8) (9) (10) mg/day of prednisone) and none of 13 in the second set of experiments did. No patient took indomethacin or other nonsteroidal anti-inflammatory drug. SLE patients studied as controls were chosen for low or absent steroid dose.
Cell separation and purification. 50 ml of heparinised blood were obtained by venepuncture (informed consent was obtained), layered on a Ficoll-Hypaque gradient in order to isolate the mononuclear cells"3; these cells were then washed 3 times in Hanks's balanced salt solution and cultured directly (first series) or processed for adherent cells (second series). T cells were obtained by passage of 2 x 107 mononuclear cells per ml over a G-200 Sephadex column to which purified rabbit antihuman F(ab)2 was conjugated. ' Comparison with SLE (Table 4) . In experiments with 13 SLE patients (repeating our prior experience8") the inhibition caused by SLE adherent cell supernates was less than the inhibition caused by PSS adherent cell supernates. The effect of indomethacin was similar in SLE and PSS supernates. group
Discussion
Adherent cells have been shown in a variety of diseases to be responsible for hyporesponsiveness of peripheral blood mononuclear cells to PHA.8 12 17 In systemic lupus erythematosus this hyporesponsiveness is associated with a cell-free inhibitory product of monocytes.9 The 
